Abstract
VEGFR-2 inhibition represents an attractive strategy for anticancer drug design. A new series of quinoline derivatives were synthesized and structurally confirmed with different spectroscopic techniques. VEGFR-2 inhibition assay showed that 2-(4-bromoquinolin-3-yloxy)-1-(4-chlorophenyl)ethanone (V) demonstrated potent VEGFR-2 inhibitory activities. In addition, the brominated quinoline (V) exhibit antitumor activity over MCF-7 cell line via cell cycle arrest at G1 phase and apoptosis inducing activity as revealed by cell cycle analysis and Annexin V/FITC staining assays. Moreover, brominated quinoline (V) was proved to upregulate expression of proteins that trigger apoptosis such as increased Bax, decreased Bcl-2 as well as increased Bax/Bcl-2 ratio.
Similar content being viewed by others
REFERENCES
Siegel, R.L., Miller, K.D., and Jemal, A., CA: Cancer J. Clin., 2016, vol. 66, pp. 7–30. https://doi.org/10.3322/caac.21332
Bray, F., Jemal, A., Grey, N., Ferlay, J., and Forman, D., Lancet Oncol., 2012, vol. 13, pp. 790–801. https://doi.org/10.1016/S1470-2045(12)70211-5
Lanza, G., Messerini, L., Gafà, R., and Risio, M., Dig. Liver Dis., 2011, vol. 43, pp. S344–S355. https://doi.org/10.1016/S1590-8658(11)60590-2
Brognard, J. and Hunter, T., Curr. Opin. Genet. Dev., 2011, vol. 21, pp. 4–11. https://doi.org/10.1016/j.gde.2010.10.012
Potente, M., Gerhardt, H., and Carmeliet, P., Cell, 2011, vol. 146, pp. 873–887. https://doi.org/10.1016/j.cell.2011.08.039
Avraamides, C.J., Garmy-Susini, B., and Varner, J.A., Nat. Rev. Cancer, 2008, vol. 8, pp. 604–617. https://doi.org/10.1038/nrc2353
Pearson, M., García-Echeverría, C., and Fabbro, D., in Protein Tyrosine Kinases, Totowa, New Jersey: Springer, Humana Press Inc., 2006, pp. 1–29. https://doi.org/10.1385/1-59259-962-1:001
Olsson, A.-K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L., Nat. Rev. Mol. Cell Biol., 2006, vol. 7, pp. 359–371. https://doi.org/10.1038/nrm1911
Lemmon, M.A. and Schlessinger, J., Cell, 2010, vol. 141, pp. 1117–1134. https://doi.org/10.1016/j.cell.2010.06.011
Sarabipour, S., Ballmer-Hofer, K., and Hristova, K., Elife, 2016, vol. 5, pp. 13 876–13 899. https://doi.org/10.7554/eLife.13876
Montagnana, M. and Lippi, G., Ann. Transl. Med., 2017, vol. 5, pp. 268–282. https://doi.org/10.21037/atm.2017.06.20
Minić, A., Van de Walle, T., Van Hecke, K., Combrinck, J., Smith, P.J., Chibale, K., and D’hooghe, M., Eur. J. Med. Chem., 2020, vol. 187, pp. 111 963–111 969. https://doi.org/10.1016/j.ejmech.2019.111963
Wang, X., Jiang, N., Zhao, S., Xi, S., Wang, J., Jing, T., Zhang, W., Guo, M., Gong, P., and Zhai, X., Bioorg. Med. Chem., 2017, vol. 25, pp. 886–896. https://doi.org/10.1016/j.bmc.2016.12.002
Afzal, O., Kumar, S., Haider, M.R., Ali, M.R., Kumar, R., Jaggi, M., and Bawa, S., Eur. J. Med. Chem., 2015, vol. 97, pp. 871–910. https://doi.org/10.1016/j.ejmech.2014.07.044
Abd El-Aleam, R.H., George, R.F., Hassan, G.S., and Abdel-Rahman, H.M., Bioorg. Chem., 2020, vol. 94, pp. 103 411–103 420. https://doi.org/10.1016/j.bioorg.2019.103411
Okten, S., Cakmak, O., Tekin, S., and Koprulu, T.K., Lett. Drug Des. Discovert., 2017, vol. 14, pp. 1415–1424. https://doi.org/10.2174/1570180814666170504150050
Mahdy, H.A., Ibrahim, M.K., Metwaly, A.M., Belal, A., Mehany, A.B.M., El-Gamal, K.M.A., El-Sharkawy, A., Elhendawy, M.A., Radwan, M.M., Elsohly, M.A., and Eissa, I.H., Bioorg. Chem., 2020, vol. 94, p. 103 422. https://doi.org/10.1016/j.bioorg.2019.103422
Soria, J.-C., DeBraud, F., Bahleda, R., Adamo, B., Andre, F., Dientsmann, R., Delmonte, A., Cereda, R., Isaacson, J., and Litten, J., Ann. Oncol., 2014, vol. 25, pp. 2244–2251. https://doi.org/10.1093/annonc/mdu390
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., and Funahashi, Y., J. Thyroid Res., 2014, vol. 2014, pp. 1–13. https://doi.org/10.1155/2014/638747
Jiang, N., Zhai, X., Li, T., Liu, D., Zhang, T., Wang, B., and Gong, P., Molecules, 2012, vol. 17, pp. 5870–5881. https://doi.org/10.3390/molecules17055870
Abdel-Mohsen, H.T., Omar, M.A., El Kerdawy, A.M., Mahmoud, A.E.E., Ali, M.M., and El Diwani, H.I., Eur. J. Med. Chem., 2019, vol. 179. pp. 707–722. https://doi.org/10.1016/j.ejmech.2019.06.063
Hradil, P., Krejčí, P., Hlaváč, J., Wiedermannová, I., Lyčka, A., and Bertolasi, V., J. Heterocycl. Chem., 2004, vol. 41, pp. 375–379. https://doi.org/10.1002/jhet.5570410311
Moustafa, A.M.Y. and Bakare, S.B., Res. Chem. Intermed., 2019, vol. 45, pp. 3895–3912. https://doi.org/10.1007/s11164-019-03827-y
Maurya, D.K., Nandakumar, N., and Devasagayam, T.P.A., J. Clin. Biochem. Nutr., 2010, vol. 48, pp. 85–90. https://doi.org/10.3164/jcbn.11-004FR
Ranganathan, S., Halagowder, D., and Sivasithambaram, N.D., PLoS One, 2015, vol. 10, p. 0141 370. https://doi.org/10.1371/journal.pone.0141370
AbdElhameid, M.K., Labib, M.B., Negmeldin, A.T., Al-Shorbagy, M., and Mohammed, M.R., J. Enzyme Inhib. Med. Chem., 2018, vol. 33, pp. 1472–1493. https://doi.org/10.1080/14756366.2018.1503654
Ren, X.-S., Yin, M.-H., Zhang, X., Wang, Z., Feng, S.-P., Wang, G.-X., Luo, Y.-J., Liang, P.-Z., Yang, X.-Q., He, J.-X., and Zhang, B.-L., Cancer Lett., 2014, vol. 344, pp. 195–203. https://doi.org/10.1016/j.canlet.2013.10.031
You, B.R., Shin, H.R., and Park, W.H., Int. J. Oncol., 2014, vol. 44, pp. 301–308. https://doi.org/10.3892/ijo.2013.2152
Zaki, I., Abdelhameid, M.K., El-Deen, I.M., Abdel Wahab, A.H.A., Ashmawy, A.M., and Mohamed, K.O., Eur. J. Med. Chem., 2018, vol. 156, pp. 563–579. https://doi.org/10.1016/j.ejmech.2018.07.003
Smirnov, L., Andronova, N., Lezina, V., Zaitsev, B., and Dyumaev, K., Bull. Acad. Sci. USSR (Div. Chem. Sci.), 1971, vol. 20, pp. 400–402. https://doi.org/10.1007/BF00869061
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human or animals participants performed by any of the authors.
Conflict of Interests
The authors declare that they have no conflicts of interest.
Additional information
Corresponding author: phone: +201153436140.
Rights and permissions
About this article
Cite this article
Islam Zaki, Amal M. Imam Design, Synthesis, and Cytotoxic Screening of New Quinoline Derivatives over MCF-7 Breast Cancer Cell Line. Russ J Bioorg Chem 46, 1099–1109 (2020). https://doi.org/10.1134/S1068162020060096
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162020060096